Single Cell Drug Screening AI Platform

To investigate tumor heterogeneity, we have developed a single-cell culture device capable of isolating and individually culturing over 1.4 million single cells for high-throughput drug testing. Leveraging our proprietary AI model, we can accurately identify drug-resistant single cells, enabling further investigation and more precise prediction of treatment efficacy. This platform accelerate cancer reserach, R&D progress for advanced therapeutics and predictive diagnostics for personalised cancer treatment.